Menu
AstraZeneca recently posted an NDC notice to 340B covered entities regarding replenishment of a cancer medication.

AstraZeneca Announces Change to Cancer Drug Replenishment After Discontinuing Certain Dosage

Bella Czajkowski, National Correspondent Views
AstraZeneca will discontinue a certain bottle dosage of its breast cancer drug Truqap (capiversatib) by the end of the year, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live